We Update you with the Clock Running. Health Care News, Disease, Diagnose, Physicians, Residents, Medical Officers, Nursing Care, Technical Staff, Health Policies, Organizations, Certification, Standards, Alerts, and All about Worlds Health. Step to Facilitate the Health Care Professionals and Patients. Provide Safety and Quality to Patient's, Health Care staff, Explains Patient Family Education and Rights.
First Patient Dosed In A Phase 1 Clinical Trial With Oral TRC102, An Inhibitor Of Chemotherapy Resistance, In Combination With AlimtaŽ
Cancer / Oncology TRACON Pharmaceuticals, Inc., announced that the first cancer patient has been treated in a Phase 1 clinical trial with oral TRC102, a novel anti-cancer drug intended to reverse resistance to AlimtaŽ chemotherapy by targeting a specific DNA repair pathway. "TRACON is taking the lead in developing oral dosing of TRC102, which will provide better patient flexibility in treatments for advanced cancers.
Custom Search
